Spots Global Cancer Trial Database for locally advanced esophageal squamous cell carcinoma
Every month we try and update this database with for locally advanced esophageal squamous cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC | NCT05522894 | Unresectable Es... Locally Advance... Metastatic Esop... | AK104 Cisplatin Paclitaxel | 18 Years - 75 Years | ChineseAMS | |
| Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma | NCT06342167 | Locally Advance... Sintilimab Radiotherapy Concurrent Chem... Immunonutrition | Radiotherapy Programmed Cell... Immunonutrition... | 18 Years - 80 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002) | NCT05520619 | Esophageal Squa... Locally Advance... | Paclitaxel, Cis... tislelizumab Radiotherapy | 18 Years - 70 Years | Sun Yat-sen University | |
| Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007) | NCT06187597 | Locally Advance... | S-1 Toripalimab Intensity-modul... | 70 Years - 85 Years | Sun Yat-sen University | |
| A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma | NCT03914443 | Locally Advance... | Nivolumab 5-FU CDDP DTX | 20 Years - 75 Years | National Cancer Center, Japan | |
| Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma | NCT06342167 | Locally Advance... Sintilimab Radiotherapy Concurrent Chem... Immunonutrition | Radiotherapy Programmed Cell... Immunonutrition... | 18 Years - 80 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma | NCT04602013 | Locally Advance... | Sintilimab Chemotherapy Radiation Thera... | 18 Years - 75 Years | Sichuan Cancer Hospital and Research Institute | |
| Immunotherapy With CCRT Followed by Surgery for Locally Advanced ESCC Patients | NCT05743504 | Locally Advance... | Tiragolumab | 20 Years - | National Taiwan University Hospital | |
| A Clinical Study on the Efficacy and Safety of Paclitaxel Polymer Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma | NCT06356688 | Locally Advance... Neoadjuvant The... | paclitaxel poly... | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007) | NCT06187597 | Locally Advance... | S-1 Toripalimab Intensity-modul... | 70 Years - 85 Years | Sun Yat-sen University | |
| Immunotherapy With CCRT Followed by Surgery for Locally Advanced ESCC Patients | NCT05743504 | Locally Advance... | Tiragolumab | 20 Years - | National Taiwan University Hospital | |
| Immunotherapy With CCRT Followed by Surgery for Locally Advanced ESCC Patients | NCT05743504 | Locally Advance... | Tiragolumab | 20 Years - | National Taiwan University Hospital | |
| A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma | NCT03914443 | Locally Advance... | Nivolumab 5-FU CDDP DTX | 20 Years - 75 Years | National Cancer Center, Japan | |
| Exploring the Safety and Effectiveness of Toripalimab Combined With Neoadjuvant Radiotherapy and Chemotherapy in the Locally Advanced Esophageal Squamous Cell Carcinoma | NCT04888403 | Locally Advance... | Toripalimab+Ned... | 18 Years - 70 Years | The First Affiliated Hospital of Zhengzhou University | |
| Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma | NCT06342167 | Locally Advance... Sintilimab Radiotherapy Concurrent Chem... Immunonutrition | Radiotherapy Programmed Cell... Immunonutrition... | 18 Years - 80 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCC | NCT03917966 | Locally Advance... | SHR-1210+doceta... SHR-1210+Apatin... | 18 Years - 80 Years | The First Affiliated Hospital of Zhengzhou University | |
| Neoadjuvant Cadonilimab Combined With Anlotinib in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma | NCT06426797 | Locally Advance... | Cadonilimab plu... | 18 Years - | Peking University People's Hospital | |
| Exploring the Safety and Effectiveness of Toripalimab Combined With Neoadjuvant Radiotherapy and Chemotherapy in the Locally Advanced Esophageal Squamous Cell Carcinoma | NCT04888403 | Locally Advance... | Toripalimab+Ned... | 18 Years - 70 Years | The First Affiliated Hospital of Zhengzhou University | |
| A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma | NCT03914443 | Locally Advance... | Nivolumab 5-FU CDDP DTX | 20 Years - 75 Years | National Cancer Center, Japan | |
| Immunotherapy With CCRT Followed by Surgery for Locally Advanced ESCC Patients | NCT05743504 | Locally Advance... | Tiragolumab | 20 Years - | National Taiwan University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
